An Epidemiological, Non-interventional Study to Evaluate Patient Compliance in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Aromatase inhibitors
- Indications Early breast cancer
- Focus Therapeutic Use
- 17 Jul 2013 Biomarkers information updated
- 07 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Feb 2011 Actual initiation date (Jan 2011) added as reported by ClinicalTrials.gov.